POH 0.00% 0.0¢ progress 2023-2 trust

Terumo and Propofol Injectable, page-38

  1. 6,900 Posts.
    lightbulb Created with Sketch. 37
    Multiple dose clinical trial (sequential x 72 hour applications)
    World’s first patch to deliver therapeutic levels of oxymorphone transdermally
    • 2 sequential patch application (in n=12), mean CMAX increases, Consistent delivery profile, Well tolerated, minimal irritation
    • 75% less oxymorphone required for pain administration vs. oxymorphone ER oral tablets over the same 72 hour period
 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
(20min delay)
Last
0.0¢
Change
0.000(0.00%)
Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.